Home
About
Overview
Sharing Data
ORCID
Help
History (24)
ß-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment.
A significant role for histocompatibility in human islet transplantation.
Mutant insulin syndrome: identification of two families with [LeuA3]insulin and determination of its biological activity.
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.
TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes. 2010 Feb; 59(2):479-85.
View in:
PubMed
subject areas
Blood Glucose
Body Composition
C-Peptide
Diabetes Mellitus, Type 2
Female
Genetic Variation
Genotype
Glucose Tolerance Test
Humans
Incretins
Insulin
Insulin-Secreting Cells
Male
Reference Values
Risk Assessment
Risk Factors
TCF Transcription Factors
Transcription Factor 7-Like 2 Protein
authors with profiles
Graeme Bell
Kenneth Polonsky